Equity · Healthcare
LENZ
NASDAQLENZ Therapeutics (LENZ)
The line runs 4.61 USD on 24 August through 2.97 USD on 20 November, on a scale from 2 to 6. Days the market did not trade hold the previous close, flat.
- Market cap
- 93.3M USD
- Revenue, year to Dec 2025
- 19.1M USD
- EPS, diluted, year to Dec 2025
- −2.85 USD
- Avg volume
- 61.1K
- Mentions, 30 days
- 2
as of Nov 20, 2026
Have LENZ Therapeutics (LENZ) insiders bought or sold shares recently?
In the 90 days to 23 Nov 2026, LENZ Therapeutics insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 27 Mar 2026.
Form 4, 90 days to 23 Nov 2026, newest reported trade 29 Oct 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 29 Oct 2026 | RA CAPITAL MANAGEMENT, L.P.10% Owner | Sell | 2,718,684 | 9.1M USD |
Which funds hold LENZ Therapeutics (LENZ)?
7 of the 45 institutional funds we track reported a LENZ Therapeutics position for the quarter ended 30 Sep 2026 — a combined 10.6M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Millennium Management | Held (±25%) | 1,159,987 | 4.5M USD | −23.1% |
| Two Sigma Investments | Added | 714,588 | 2.7M USD | +150.2% |
| Marshall Wace | Trimmed | 289,473 | 1.1M USD | −41.3% |
| D. E. Shaw & Co. | New position | 187,027 | 718K USD | |
| Renaissance Technologies | Added | 181,788 | 698K USD | +157.4% |
| AQR Capital Management | Trimmed | 125,836 | 483K USD | −44.7% |
| Citadel Advisors | Trimmed | 95,325 | 366K USD | −73.8% |
What has been filed or recorded for LENZ Therapeutics (LENZ)?
The filings we hold for LENZ Therapeutics, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Oct 2026 | Fails to deliver | Shares failed to deliver | 475,246 shares | 1.7M USD notional · 1.513% of shares out |
| 22 Oct 2026 | Fails to deliver | Shares failed to deliver | 2,999 shares | 10K USD notional · 0.010% of shares out |
| 16 Oct 2026 | Fails to deliver | Shares failed to deliver | 30,567 shares | 109K USD notional · 0.097% of shares out |
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 3,481 shares | 12K USD notional · 0.011% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 25,761 shares | 93K USD notional · 0.082% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 8,174 shares | 29K USD notional · 0.026% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 9,129 shares | 33K USD notional · 0.029% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.99 USD | Revenue $3M |
| 30 Sep 2026 | Financials | Total assets | 209.7M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 192.0M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −1.02 USD | Revenue $5M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −1.32 USD | Revenue $2M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −2.85 USD | Revenue $19M |
| 31 Dec 2025 | Financials | Revenue | 19.1M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −82.1M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −2.85 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.59 USD | Revenue $13M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.53 USD | Revenue $5M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.53 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −2.34 USD |
What is Reddit saying about LENZ Therapeutics (LENZ)?
Reddit mentioned LENZ 2 times in the 30 days to 22 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 50% read bullish, 0% bearish and 50% neither. Reddit data updated 22 November 2026.
30-day window, Method
How do Reddit mentions of LENZ Therapeutics (LENZ) compare with its price?
Share ↗
Which subreddits are talking about LENZ Therapeutics (LENZ)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 2 | +0.04 |
What do people ask about LENZ Therapeutics (LENZ)?
What did LENZ Therapeutics shares close at?2.97
LENZ Therapeutics closed at 2.97 USD on 20 Nov 2026, down 11.08% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is LENZ Therapeutics’ market cap?93.3M
LENZ Therapeutics is worth 93.3M USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is LENZ Therapeutics’ revenue?19.1M
LENZ Therapeutics reported revenue of 19.1M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have LENZ Therapeutics insiders bought or sold shares recently?1 sale
In the 90 days to 23 Nov 2026, LENZ Therapeutics insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 27 Mar 2026. See Insiders
Which funds own LENZ Therapeutics?7 of 45
7 of the 45 funds we track reported a LENZ Therapeutics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Two Sigma Investments and Marshall Wace. See Funds
When did LENZ Therapeutics last report earnings?−0.99
LENZ Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.99 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about LENZ Therapeutics?0 mentions
LENZ Therapeutics was mentioned 0 times in the last 7 days across the finance subreddits we track, and 2 times over the trailing 30 days. Of the 2 mentions scored for sentiment, 50% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words